Skip to content
  • Wednesday, 19 August 2026
  • 11:12 pm
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Neuroscience & Brain Research

King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286

Rifan Muazin Jul 25, 2026 0

Researchers at King’s College London have identified a promising new therapeutic strategy for Alzheimer’s disease by targeting several of the…

Read More
Stem Cell & Regenerative Medicine

Yale Researchers Uncover Molecular Mechanism Behind Anti-Sperm Antibodies Providing New Pathways for Infertility Treatment and Male Contraception

Dwi Wanna Jul 23, 2026 0

A multidisciplinary research team led by Yale University has successfully mapped the molecular architecture of a naturally occurring biological mechanism…

Read More
Pharmaceutical R&D

New Therapies Usher in Era of Personalised Treatment for Rare Blood Cancers

Teuku Ryan Jul 21, 2026 0

A significant advancement in the treatment of rare blood cancers is set to transform the lives of approximately 200 patients…

Read More
Laboratory Automation & Robotics

Johnson & Johnson’s Spravato Remission Data Takes Center Stage in Push for Treatment-Resistant Depression Growth

Lana Keisha Jul 19, 2026 0

A recent poster presentation at Psych Congress Elevate by Johnson & Johnson has placed esketamine nasal spray, marketed as Spravato,…

Read More
Pharmaceutical R&D

Novartis Fabhalta Receives Traditional FDA Approval for IgAN Treatment

Teuku Ryan Jul 19, 2026 0

The U.S. Food and Drug Administration (FDA) has granted traditional approval to Novartis for Fabhalta (iptacopan), a groundbreaking oral Factor…

Read More
Stem Cell & Regenerative Medicine

Discovery of Fam102a as a Dual Regulator in Bone Remodeling Offers New Pathway for Osteoporosis Treatment

Dwi Wanna Jul 18, 2026 0

The landscape of regenerative medicine and endocrinology has shifted following the landmark identification of a novel protein that serves as…

Read More
Pharmaceutical R&D

Kerendia Recommended for Broader Heart Failure Treatment in England, Offering New Hope for Patients with Preserved Ejection Fraction

Teuku Ryan Jul 17, 2026 0

England’s National Health Service (NHS) is set to expand its treatment options for chronic heart failure (CHF) with the National…

Read More
Neuroscience & Brain Research

King’s College London Researchers Identify KCL-286 as a Multitarget Breakthrough for Early-Stage Alzheimer’s Treatment

Rifan Muazin Jul 17, 2026 0

The landscape of neurodegenerative research has shifted significantly following a landmark discovery by scientists at King’s College London (KCL), who…

Read More
Stem Cell & Regenerative Medicine

Yale Researchers Uncover Molecular Mechanism of Anti-Sperm Antibodies Providing New Pathways for Infertility Treatment and Contraceptive Innovation

Dwi Wanna Jul 16, 2026 0

A multidisciplinary research team led by Yale University has successfully mapped the precise biological mechanism by which a naturally occurring…

Read More
Biotech & Genetic Research

Bionic Cooling Skin Revolutionizes Infected Wound Treatment with Dual-Action Protection and Healing

Jia Lissa Jul 15, 2026 0

A groundbreaking innovation from The Hong Kong Polytechnic University (PolyU) promises to transform the landscape of wound care, particularly for…

Read More

Posts pagination

1 2 … 13
Pi Coding Agents: A Deep Dive into the Minimalist AI Assistant Challenging Industry NormsA Microscopic Organism at Oxford Rewrites the Rules of Life’s Genetic CodeEli Lilly and Ascidian Therapeutics Forge Strategic Alliance to Pioneer Novel Genetic Medicines for Kidney DiseasesMicroplastics and Neurodegeneration: New Research Links Synthetic Particles to Alzheimer’s and Parkinson’s Disease Risks
Japan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactMEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ